 | Eterna Therapeutics Inc. | |||
| NCM : ERNA || Location: United States | ||||
$1.81+0.07 (+4.02%) |
0.01 M | 1.73 - 1.89 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.040 M |
| March 28, 2024 | 0.042 M |
| March 15, 2024 | 0.034 M |
| Feb. 29, 2024 | 0.038 M |
| Feb. 15, 2024 | 0.147 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2022 | -2.20 | -2.49 | -13.20% |
| 06/30/2022 | -2.60 | -1.20 | 53.80% |
| 03/31/2022 | -2.80 | -3.40 | -21.40% |
| 12/31/2021 | -2.50 | -3.20 | -28.00% |
| 09/30/2021 | -1.60 | -2.20 | -37.50% |
ERNA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 5.410M | Shares Float | 2.953M |
| Short Float | 0.040M | Market Cap | 9.41M |
| Institution ownership | 16.19% | Insider ownership | 39.307% |
| Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -4.08 | Forward EPS | -9.60 |